Friday 19 April 2024

New Nanostructures Findings from University of Santiago Described

Fresh data on Nanostructures are presented in a new report. According to news reporting originating inSantiago de Compostela, Spain, by NewsRx journalists, research stated, “The unique ability of cyclodextrins (CDs) to form inclusion complexes can be transmitted to polymeric networks in which CDs are chemically grafted or cross-linked. Combination of CDs and hydrogels in a single material leads to synergic properties: the hydrophilic network enhances biocompatibility and prevents dilution in the physiological medium increasing the stability of the inclusion complexes, while CDs finely tune the mechanical features and the stimuli-responsiveness and provide affinity-based regulation of drug loading and release.”

The news reporters obtained a quote from the research from the University of Santiago, “Therefore, CD-functionalized materials are opening new perspectives in pharmacotherapy, emerging as advanced delivery systems (DDS) for hydrophobic and hydrophilic drugs to be administered via almost any route. Medical devices (catheters, prosthesis, vascular grafts, bone implants) can also benefit from surface grafting or thermofixation of CDs. The present review focuses on the approaches tested to synthesize nano- to macro-size covalently cross-linked CD networks: i) direct cross-linking through condensation with di- or multifunctional reagents, ii) copolymerization of CD derivatives with acrylic/vinyl monomers, and iii) grafting of CDs to preformed medical devices”.

Publicidade

According to the news reporters, the research concluded: “Examples of the advantages of having the CDs chemically bound among themselves and to substrates are provided and their applicability in therapeutics discussed”.

 

DEIXAR UNHA RESPOSTA

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Relacionadas

USC Researchers reveal an essential process in bacteria causing tuberculosis

The work of CIQUS has been highlighted as Spotlight by the Biochemical Journal, would enable the development of new antibiotics